北京万泰生物药业股份有限公司 关于全资子公司完成工商变更登记 并换发营业执照的公告

Core Viewpoint - The announcement details the completion of business registration changes and the issuance of a new business license for Xiamen Wantai Kerry Biotechnology Co., Ltd., a wholly-owned subsidiary of Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. [1] Group 1: Company Information - The subsidiary, Xiamen Wantai Kerry, has changed its business scope and address, moving from "124 Xinyuan Road, Haicang District, Xiamen" to "9-1 Hutu Road, Haicang District, Xiamen" [1] - The new business license was issued by the Market Supervision Administration of Haicang District, Xiamen [1] - The company is a limited liability entity with a registered capital of 500 million yuan [1] Group 2: Business Scope - The business scope includes the production and operation of Class III medical devices, rental of Class III medical equipment, production of pharmaceuticals, and import/export of pharmaceuticals [1] - General projects include the production and sale of Class I and II medical devices, rental of Class II medical equipment, sales of plastic products, and various technical services [1]